Loading
A phase 1 trial of Tozuleristide run by Blaze Bioscience Inc., withdrawn before enrolling.
Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery is a phase 1 interventional study registered as NCT02464332 by Blaze Bioscience Inc., started 2015-09. Conditions recorded: Sarcoma, Soft Tissue. Interventions recorded: BLZ-100.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Tozuleristide, Blaze Bioscience and the tag pipeline.
Shares Sarcomas (soft tissue, bone, GIST) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/